GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 98 filers reported holding GENERATION BIO CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,666 | -31.1% | 2,814,191 | 0.0% | 0.46% | -4.8% |
| Q2 2023 | $15,478 | +27.9% | 2,814,191 | 0.0% | 0.48% | -33.2% |
| Q1 2023 | $12,101 | +9.4% | 2,814,191 | 0.0% | 0.72% | +16.5% |
| Q4 2022 | $11,060 | -99.9% | 2,814,191 | 0.0% | 0.62% | -3.3% |
| Q3 2022 | $14,943,000 | -19.1% | 2,814,191 | 0.0% | 0.64% | -35.3% |
| Q2 2022 | $18,461,000 | -10.6% | 2,814,191 | 0.0% | 0.99% | +14.0% |
| Q1 2022 | $20,656,000 | +3.7% | 2,814,191 | 0.0% | 0.86% | +59.9% |
| Q4 2021 | $19,924,000 | -71.8% | 2,814,191 | 0.0% | 0.54% | -65.7% |
| Q3 2021 | $70,552,000 | -6.8% | 2,814,191 | 0.0% | 1.58% | +2.8% |
| Q2 2021 | $75,702,000 | -5.5% | 2,814,191 | 0.0% | 1.54% | +8.6% |
| Q1 2021 | $80,092,000 | +0.4% | 2,814,191 | 0.0% | 1.42% | -17.4% |
| Q4 2020 | $79,782,000 | -8.3% | 2,814,191 | 0.0% | 1.71% | -18.9% |
| Q3 2020 | $86,987,000 | +47.2% | 2,814,191 | 0.0% | 2.11% | +27.7% |
| Q2 2020 | $59,098,000 | – | 2,814,191 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |